Skip to main content

Advertisement

Log in

Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents

The Bergen district nursing home (BEDNURS) study

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Aims

To investigate drug use relative to mental functioning and to explore the use of inappropriate drugs and potentially harmful drug combinations in nursing home residents.

Methods

Cross-sectional study in 15 nursing homes (1042 long-term care residents) in Bergen, Norway. Information on individual patients' scheduled drug use was obtained from drug dispensing cards. Mental functioning was assessed by means of the Clinical Dementia Rating scale. Drug use was considered inappropriate according to approved expert consensus criteria. Drug–drug interactions were considered relevant according to the national standard. Classification of interactions was based on pharmacokinetic and pharmacodynamic principles.

Results

Mentally intact residents used significantly more scheduled drugs than the mentally impaired (mean 6.2 vs 4.8, P<0.001). The mentally intact used generally more of all types of drugs, in particular hypnotics, cardiovascular and pain-relieving drugs. Of all drug users, 25.3% received inappropriate medications, comprising 6.2% of all drugs issued. Fewer mentally impaired residents received inappropriate drugs (21.6% vs 44.2%, P<0.001). Of the residents, 95 received 101 potentially harmful two-by-two drug combinations (1.9% of all prescriptions). The number of drugs used was weakly associated with inappropriate drugs (r=0.33, P<0.001) and with potentially harmful two-by-two drug combinations (r=0.27, P<0.001).

Conclusion

The study shows considerable differences in drug use between mentally impaired and mentally intact nursing-home residents that may only partly be explained by a diagnostic selection effect. Mentally impaired residents are at greater risk of not receiving appropriate treatment for their complaints, but they are also less liable to suffer from hazards caused by inappropriate drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Col N, Fanale JE, Kronholm P (1989) The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150:841–845

    Article  Google Scholar 

  2. Lindley CM, Tully MP, Paramsothy V, Tallis RC (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 21:294–300

    CAS  PubMed  Google Scholar 

  3. Hallas J, Gram LF, Grodum E, Damsbo N, Brøsen K, Hagfelt T, Harvald B, Beck-Nielsen J, Worm J, Jensen KB, Davidsen O, Frandsen NE, Hagen C, Andersen M, Frølund F, Kromann-Andersen H, Schou J (1992) Drug related admission to medical wards: a population based study. Br J Clin Pharmacol 33:61–68

    CAS  PubMed  Google Scholar 

  4. Ebbesen J, Buajordet I, Erikssen J, Brørs O, Hilberg T, Svaar H, Sandvik L (2001) Drug-related deaths in a department of internal medicine. Arch Intern Med 161:2317–2323

    Article  CAS  PubMed  Google Scholar 

  5. Mustard C, Mayer T (1997) Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol 145:738–745

    CAS  PubMed  Google Scholar 

  6. Nygaard HA, Rotevatn TS, Brudvik E, Juvik OB, Pedersen E-W (1995) Medikamentforbruk hos sykehjemspasienter. Endringer i løpet av de første tre månedene (Drug consumption in nursing home residents. Changes during the first three months). Tidsskr Nor Laegeforen 115:829–831

    CAS  PubMed  Google Scholar 

  7. Wills P, Claesson CB, Fratiglioni L, Fastbom J, Thorslund M, Winblad B (1997) Drug use by demented and non-demented elderly people. Age Ageing 26:383–391

    CAS  PubMed  Google Scholar 

  8. Avorn J, Gurwitz JH (1995) Drug use in the nursing home. Ann Intern Med 123:195–204

    CAS  PubMed  Google Scholar 

  9. Weyerer S, Mann A, Ames D (1995) Prävalenz von Depressionen und Demenz bei Altenheimbewohnern in Mannheim und Camden (London). Z Gerontol Geriatr 28:169–178

    CAS  PubMed  Google Scholar 

  10. Renner EA, Engle VF, Graney MJ (1992) Prevalence and predictors of regularly scheduled prescription medications of newly admitted nursing home residents. J Am Geriatr Soc 40:232–236

    CAS  PubMed  Google Scholar 

  11. Horgas AL, Tsai P-F (1998) Analgesic drug prescription and use in cognitively impaired nursing home residents. Nursing Res 47:235–242

    CAS  Google Scholar 

  12. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for staging of dementia. Br J Psychiatry 140:566–572

    CAS  PubMed  Google Scholar 

  13. Juva K, Sulkava R, Erkinjuntti T, Yliksoski R, Valvanne H, Tilvis R (1995) Usefulness of the clinical dementia rating scale in screening for dementia. Int Psychogeriatr 7:17–24

    CAS  PubMed  Google Scholar 

  14. Nygaard HA, Breivik K, Bakke K, Brudvik E, Moe TJ (1987) Dementia and work load evaluation of the elderly. Compr Gerontol 1:65–68

    CAS  Google Scholar 

  15. Nygaard H, Ruths S (2003) Missing the diagnosis: senile dementia in patients admitted to nursing homes. Scand J Prim Health Care 21:(in press)

  16. World Health Organization (1997) Anatomical Therapeutical Chemical (ATC) classification index including defined daily doses (DDD) for plain substances. World Health Organisation Collaborating Centre for Drug Statistics Methodology, Oslo

  17. Beers MH (1997) Explicit criteria for determining potential inappropriate medication use by the elderly. An update. Ach Intern Med 157:1531–1536

    Article  CAS  Google Scholar 

  18. Spigset O, Krumsvik IL (2002) Legemiddelinteraksjoner. (Drug interactions). In: Tørisen HM (ed) Felleskatalogen. (Norwegian Pharmaceutical Product Compendium, 44th edn.) (in Norwegian) Felleskatalogen, Oslo, pp 1e–132e

  19. Hansten PD, Horn JR (2000) Drug interactions. Analysis and management. St. Louis: facts and comparison

  20. Folstein MF, Folstein SE, McHuge PR (1975) Mini-mental-state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    CAS  PubMed  Google Scholar 

  21. Wolf-Klein GP, Silverstone FA, Brod MS, Levy A, Foley CJ, Termotto V, Breuer J (1988) Are Alzheimer patients healthier? J Am Geriatr Soc 36:219–224

    CAS  PubMed  Google Scholar 

  22. Landi F, Gambassi G, Lapane KL, Sgadari A, Gifford D, Mor V, Bernabei R (1998) Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord 9:347–356

    CAS  PubMed  Google Scholar 

  23. Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, Varricchio M, Rengo F (1997) Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 46:1343–1348

    Google Scholar 

  24. McCormick WC, Kukull WA, van Belle G, Bowen JD, Teri L (1994) Symptoms patterns and comorbidity in the early stage of Alzheimer's disease. J Am Geriatr Soc 42:517–521

    CAS  PubMed  Google Scholar 

  25. Rosholm J-U, Christensen K (1997) Relationship between drug use and self-reported health in elderly Danes. Eur J Clin Pharmacol 53:179–183

    Article  CAS  PubMed  Google Scholar 

  26. Monane M, Avorn J, Beers MH, Everitt E (1993) Anticholinergic drug use and bowel function in nursing home residents. Arch Intern Med 153:633–638

    Article  CAS  PubMed  Google Scholar 

  27. van Dijk KN, de Vries CS, van den Berg PB, Dijkema AM, Brouwers JRBJ, de Jong-van den Berg LTW (1998) Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk. Br J Clin Pharmacol 46:255–261

    Article  PubMed  Google Scholar 

  28. Kivipelto M, Helkala E-L, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissien A (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322:1447–1451

    Article  CAS  PubMed  Google Scholar 

  29. Zekry D, Hauw J-J, Gold G (2002) Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 50:1431–1439

    Article  PubMed  Google Scholar 

  30. AGS panel on persistent pain in older persons (2002) The management of persistent pain in older persons. J Am Geriatr Soc 50:S205–S224

    PubMed  Google Scholar 

  31. Ruths S, Straand J, Nygaard H (2001) Psychotropic drug use in nursing homes—diagnostic indications and variations between institutions. Eur J Clin Pharmacol 57:523–528

    Article  CAS  PubMed  Google Scholar 

  32. Hughes CM, Lapane KL, Mor V, Ikegami N, Jónsson PV, Ljunggren G, Sgadari A (2000) The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 48:931–937

    CAS  PubMed  Google Scholar 

  33. Medical Products Agency and The Norwegian Medicines Control Authority (1995) Treatment of mental conditions in patients with dementia. Workshop, Uppsala, 1994

  34. Burke W (1991) Neuroleptic drug use in the nursing home: the impact of OBRA. Am Fam Physician 43:2125–2130

    CAS  PubMed  Google Scholar 

  35. Aparasu RR, Mort JR (2000) Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 34:338–346

    CAS  PubMed  Google Scholar 

  36. Piecoro L, Browning S, Scott Prince T, Ranz T, Scutchfield F (2000) A database analysis of potentially inappropriate drug use in an elderly medicaid population. Pharmacotherapy 20:221–228

    CAS  PubMed  Google Scholar 

  37. Sloane PD, Zimmerman S, Brown LC, Ives TJ, Walsh JF (2002) Inappropriate medication prescribing in residential care/assisted living facilities. J Am Geriatr Soc 50:1001–1011

    Article  PubMed  Google Scholar 

  38. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB, and the Pharmaceutical Care of the Elderly in Europe Research (PEER) Group (2002) Drug–drug interactions in the elderly. Ann Pharmacother 36:1675–1681

    Article  PubMed  Google Scholar 

  39. Giron MS, Wang H-X, Bernsten C, Thorslund M, Winblad B, Fastbom J (2001) The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 49:277–283

    Article  CAS  PubMed  Google Scholar 

  40. van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRBJ, de Jong-van den Berg LTW (2001) Occurrence of potential drug–drug interactions in nursing home residents. Int J Pharm 9:45–52

    Google Scholar 

  41. Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, Ménard JF, Bercoff E (1996) Drug–drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 44:944–948

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Sabine Ruths has been supported by grants from The National Geriatric Program (NGP) and The Norwegian National Health Association (Nasjonalforeningen for folkehelsen).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harald A. Nygaard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nygaard, H.A., Naik, M., Ruths, S. et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. Eur J Clin Pharmacol 59, 463–469 (2003). https://doi.org/10.1007/s00228-003-0646-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-003-0646-7

Keywords

Navigation